Correlation Between Eurobio Scientific and Theradiag

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eurobio Scientific and Theradiag at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eurobio Scientific and Theradiag into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eurobio Scientific SA and Theradiag SA, you can compare the effects of market volatilities on Eurobio Scientific and Theradiag and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eurobio Scientific with a short position of Theradiag. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eurobio Scientific and Theradiag.

Diversification Opportunities for Eurobio Scientific and Theradiag

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eurobio and Theradiag is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Eurobio Scientific SA and Theradiag SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theradiag SA and Eurobio Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eurobio Scientific SA are associated (or correlated) with Theradiag. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theradiag SA has no effect on the direction of Eurobio Scientific i.e., Eurobio Scientific and Theradiag go up and down completely randomly.

Pair Corralation between Eurobio Scientific and Theradiag

Assuming the 90 days trading horizon Eurobio Scientific SA is expected to generate 0.06 times more return on investment than Theradiag. However, Eurobio Scientific SA is 17.98 times less risky than Theradiag. It trades about 0.04 of its potential returns per unit of risk. Theradiag SA is currently generating about -0.12 per unit of risk. If you would invest  2,580  in Eurobio Scientific SA on August 28, 2024 and sell it today you would earn a total of  5.00  from holding Eurobio Scientific SA or generate 0.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eurobio Scientific SA  vs.  Theradiag SA

 Performance 
       Timeline  
Eurobio Scientific 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Eurobio Scientific SA are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Eurobio Scientific is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Theradiag SA 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Theradiag SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Theradiag reported solid returns over the last few months and may actually be approaching a breakup point.

Eurobio Scientific and Theradiag Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eurobio Scientific and Theradiag

The main advantage of trading using opposite Eurobio Scientific and Theradiag positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eurobio Scientific position performs unexpectedly, Theradiag can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theradiag will offset losses from the drop in Theradiag's long position.
The idea behind Eurobio Scientific SA and Theradiag SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance